/PRNewswire/ Aria Pharmaceuticals, a pharmaceutical company focused on bringing first-in-class small molecules to market, today announced that its lead.
Lung disease specialist takes up chair named for mentor
Will continue his ground-breaking research in Interstitial Lung Disease (ILD) 18-May-2021 10:15 AM EDT, by McMaster University
McMaster University
Martin Kolb is research director at the Firestone Institute for Respiratory Health at McMaster and St. Joseph’s Healthcare Hamilton, as well as division director for respirology at the Department of Medicine.
Newswise Hamilton, ON (May 18, 2021) – People with incurable lung diseases have a powerful champion in McMaster University’s Martin Kolb.
Kolb begins his five-year appointment as the inaugural Jack Gauldie Boehringer Ingelheim Chair in Interstitial Lung Disease (ILD) on July 1, and he will continue his ground-breaking research into this group of incurable and often-lethal respiratory illnesses.